These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19845000)

  • 21. Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.
    Scherfler C; Khan NL; Pavese N; Lees AJ; Quinn NP; Brooks DJ; Piccini PP
    Mov Disord; 2006 Jun; 21(6):783-8. PubMed ID: 16511856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
    Criswell SR; Perlmutter JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
    Neurology; 2011 Apr; 76(15):1296-301. PubMed ID: 21471467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease.
    Varrone A; Pellecchia MT; Amboni M; Sansone V; Salvatore E; Ghezzi D; Garavaglia B; Brice A; Brunetti A; Bonavita V; De Michele G; Salvatore M; Pappatà S; Barone P
    Neurology; 2004 Dec; 63(11):2097-103. PubMed ID: 15596756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
    Burn DJ; Sawle GV; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
    Brooks DJ; Playford ED; Ibanez V; Sawle GV; Thompson PD; Findley LJ; Marsden CD
    Neurology; 1992 Aug; 42(8):1554-60. PubMed ID: 1641153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.
    Tai YF; Hoshi R; Brignell CM; Cohen L; Brooks DJ; Curran HV; Piccini P
    Neuropsychopharmacology; 2011 Mar; 36(4):735-43. PubMed ID: 21160467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
    Otsuka M; Ichiya Y; Hosokawa S; Kuwabara Y; Tahara T; Fukumura T; Kato M; Masuda K; Goto I
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders.
    Stormezand GN; Chaves LT; Vállez García D; Doorduin J; De Jong BM; Leenders KL; Kremer BPH; Dierckx RAJO
    Neuroimage Clin; 2020; 25():102161. PubMed ID: 31981888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.
    Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG;
    Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-onset Parkinson's disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study.
    Shyu WC; Lin SZ; Chiang MF; Pang CY; Chen SY; Hsin YL; Thajeb P; Lee YJ; Li H
    Parkinsonism Relat Disord; 2005 May; 11(3):173-80. PubMed ID: 15823482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
    Turjanski N; Bhatia K; Burn DJ; Sawle GV; Marsden CD; Brooks DJ
    Neurology; 1993 Aug; 43(8):1563-8. PubMed ID: 8351012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of L-dopa on subtle motor signs in heterozygous Parkin- and PINK1 mutation carriers.
    Weissbach A; König IR; Hückelheim K; Pramstaller PP; Werner E; Brüggemann N; Tadic V; Lohmann K; Bäumer T; Münchau A; Kasten M; Klein C
    Parkinsonism Relat Disord; 2017 Sep; 42():95-99. PubMed ID: 28716427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal premotor-motor interaction in heterozygous Parkin- and Pink1 mutation carriers.
    Weissbach A; Bäumer T; Pramstaller PP; Brüggemann N; Tadic V; Chen R; Klein C; Münchau A
    Clin Neurophysiol; 2017 Jan; 128(1):275-280. PubMed ID: 27843055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
    Whone AL; Watts RL; Stoessl AJ; Davis M; Reske S; Nahmias C; Lang AE; Rascol O; Ribeiro MJ; Remy P; Poewe WH; Hauser RA; Brooks DJ;
    Ann Neurol; 2003 Jul; 54(1):93-101. PubMed ID: 12838524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease.
    Gallagher CL; Oakes TR; Johnson SC; Chung MK; Holden JE; Bendlin BB; McLaren DG; Xu G; Nickles RJ; Pyzalski R; DeJesus O; Brown WD
    Mov Disord; 2011 Mar; 26(4):614-20. PubMed ID: 21449008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
    Morrish PK; Rakshi JS; Bailey DL; Sawle GV; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):314-9. PubMed ID: 9527140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset pattern of nigrostriatal denervation in early Parkinson's disease.
    Pineda-Pardo JA; Sánchez-Ferro Á; Monje MHG; Pavese N; Obeso JA
    Brain; 2022 Apr; 145(3):1018-1028. PubMed ID: 35349639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.